News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kane Biotech Inc. (KNE) Retains BioVectra to Manufacture DispersinB(TM)


3/4/2008 10:13:54 AM

WINNIPEG, MANITOBA--(Marketwire - March 04, 2008) - Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, is pleased to announce that it has retained BioVectra Inc., a biopharmaceutical company in Atlantic Canada, to manufacture clinical grade DispersinBâ„¢ to be used in the Company's wound care product being developed for treating chronic wounds.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES